Jordi Mestres

CEO

Chemotargets

Biography

Jordi Mestres holds a PhD in Computational Chemistry from the University of Girona. After a post-doctoral stay at Pharmacia&Upjohn in Kalamazoo (Michigan, USA), in 1997 he joined the Molecular Design & Informatics department at N.V. Organon in Oss (The Netherlands) and in 2000 he was appointed Head of Computational Medicinal Chemistry at Organon Laboratories in Newhouse (Scotland, UK).

In 2003, he took on a position as Head of the Research Group on Systems Pharmacology, within the Research Program on Biomedical Informatics at the IMIM Hospital del Mar Medical Research Institute, in Barcelona, that he held until 2023. Between 2004 and 2022, he was also Associate Professor at the University Pompeu Fabra (UPF), in Barcelona. In 2006, he founded Chemotargets as a spin-off company of his academic group. Since October 2023, he is Visiting Professor at the University of Girona.

He is the recipient of the 2006 Corwin Hansch Award from the QSAR and Modelling Society and the 2007 Technology Transfer Award from the UPF. In 2018, he was admitted as a Fellow of the Royal Society of Chemistry. His current interests focus on the development of an AI/ML structure-based generative platform for precision drug discovery. He is the author of over 180 publications, 10 patents among them.